Late onset of tacrolimus‐related posterior leukoencephalopathy after living donor liver transplantation
Nils R. Frühauf, Susanne Koeppen, Fuat H. Saner, Thomas Egelhof, Gregor Stavrou, Silvio Nadalin, Christoph E. Broelsch – 30 December 2003 – Neurotoxicity is a well‐known side effect of tacrolimus‐based immunosuppression after liver transplantation. Until now, only 31 cases of immunosuppression‐associated leukoencephalopathy in liver transplant recipients reported in the literature are related to tacrolimus therapy. We report a patient who developed a posterior leukoencephalopathy syndrome, secondary to tacrolimus‐based immunosuppression, after living donor liver transplantation.